focus -WSS

focus

author：explore 2025-09-28 05:04:36 - browse：2341

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout LOUD podcast: Merger Mondays, Ozempic panic

WSS

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Pregnancy ages women, but effects reverse after delivery

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Bring on the sabbaticals for nurses

Peter Marks talks Operation Warp Speed for Rare Diseases

Wikipedia

focus

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Peter Marks talks Operation Warp Speed for Rare Diseases

In age of alternative facts, a scholarly course on calling out crap

Humana CEO Bruce Broussard to step down in 2024

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Massive project maps cells in human brain in unprecedented detail

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Illumina, CRISPR, Regeneron

Medical records are filled with copy

Readout LOUD podcast: Merger Mondays, Ozempic panic

leisure time

Surgeons perform first xenotransplant using CRISPR'd pig kidney

CRISPR technology availability, affordability needs to be expanded

Readout LOUD podcast, live from the STAT Breakthrough Summit East

U.K. officials, researchers try to ease path for bespoke genetic treatments

Chinese researcher claims birth of first gene

Biotech investment managers search for lucrative opportunities

knowledge

entertainment

focus

explore